News

Latest News News

Physician burnout: An Emerging National Epidemic

Results of two studies published in the latest issue of the JAMA…

Sudarshana Datta, M.D.

Apple Watch Series 4 Receives FDA Approval as a Class II Medical Device

The Apple watch series 4 received FDA approval as a class II…

Ahmed Younes, M.D.

Early Discharge Following Uncomplicated TAVR Safe, According to a Meta-Analysis

A recent meta-analysis published in the Journal of American College of Cardiology…

Ahmed Younes, M.D.

ASPREE: Another Warning Bell for Aspirin, “Wonder Drug”Fails to Work Wonders

The results of the Aspirin in Reducing Events in the Elderly (ASPREE)…

Sudarshana Datta, M.D.

Do Valsartan Contaminants NDMA and NDEA Bear A Potential Cancer Risk?

The discovery of Valsartan products that were contaminated with NDMA, in July…

Sudarshana Datta, M.D.

Can TTR levels Determine Long-term Prognosis in AFib Patients on Vitamin K Antagonists?

Findings from a Danish nationwide registry conducted among patients with Atrial Fibrillation…

Sudarshana Datta, M.D.

Operator Experience of Atleast 225 Procedures Associated With Improved TAVR Outcomes

Findings from an international TAVR registry involving 16 centers and spanning over…

Sudarshana Datta, M.D.

Angiographic Completeness Not Associated With Outcomes Following FFR-guided PCI

Researchers have confirmed that the extent of residual angiographic disease calculated using…

Sudarshana Datta, M.D.

UK based RCT Emphasizes on Long Term Cardiovascular Benefits of Antihypertensives and Statins

The Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Legacy Study is a UK based…

Sudarshana Datta, M.D.

Treating the culprit lesion associated with decreased mortality versus immediate multi-vessel PCI in cardiogenic shock

 In a randomized multi-center clinical trial that enrolled more than 700 patients…

Syed Hassan Abbas Kazmi

Coronary Microvascular Dysfunction: A Promising Therapeutic Target in Heart Failure with Preserved EF?

PROMIS-HFpEF (PRevalence Of MIcrovascular dySfunction in Heart Failure with Preserved Ejection Fraction)…

Sudarshana Datta, M.D.

Lorcaserin proven safe as weight loss agent in obese patients

The selective serotonin 2c receptor agonist, Lorcaserin has been proven to be…

Sudarshana Datta, M.D.

Cancelled Cath Lab Activation Based on Prehospital EKG, A Single Center Study

A new single-center study has shown that the catheterization laboratory (CCL) activation…

Ahmed Younes, M.D.

Omega-3 fatty acid Supplements Show No Benefit in Cardiovascular Prevention in Diabetes

A randomized trial in patients with diabetes without evidence of cardiovascular disease…

Sudarshana Datta, M.D.

Aspirin Vs Placebo In Cardiovascular Event Reduction In Diabetes

A randomized 15,480 patient strong UK based trial comparing Aspirin (ASA) versus…

Sudarshana Datta, M.D.

Antithrombotic therapy post TAVR: A double edged sword?

A multicenter, prospective nation-wide French registry evaluated whether oral anticoagulation therapy was…

Sudarshana Datta, M.D.

Conservative Management Should be First Line Therapy for SCAD

Spontaneous coronary artery dissection (SCAD) is an underdiagnosed, poorly misunderstood condition. The…

Sudarshana Datta, M.D.

High LDL Levels Can Increase Cardiovascular Mortality Even in Low Risk Population

A recent study published in Circulation found that higher levels of low-density…

Sudarshana Datta, M.D.